These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 32418059)
1. Doxorubicin sensitizes cancer cells to Smac mimetic via synergistic activation of the CYLD/RIPK1/FADD/caspase-8-dependent apoptosis. Yang C; Ran Q; Zhou Y; Liu S; Zhao C; Yu X; Zhu F; Ji Y; Du Q; Yang T; Zhang W; He S Apoptosis; 2020 Jun; 25(5-6):441-455. PubMed ID: 32418059 [TBL] [Abstract][Full Text] [Related]
3. TNF-alpha induces two distinct caspase-8 activation pathways. Wang L; Du F; Wang X Cell; 2008 May; 133(4):693-703. PubMed ID: 18485876 [TBL] [Abstract][Full Text] [Related]
4. Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked. Hannes S; Abhari BA; Fulda S Cancer Lett; 2016 Sep; 380(1):31-8. PubMed ID: 27267809 [TBL] [Abstract][Full Text] [Related]
5. A novel Smac mimetic APG-1387 demonstrates potent antitumor activity in nasopharyngeal carcinoma cells by inducing apoptosis. Li N; Feng L; Han HQ; Yuan J; Qi XK; Lian YF; Kuang BH; Zhang YC; Deng CC; Zhang HJ; Yao YY; Xu M; He GP; Zhao BC; Gao L; Feng QS; Chen LZ; Yang L; Yang D; Zeng YX Cancer Lett; 2016 Oct; 381(1):14-22. PubMed ID: 27424523 [TBL] [Abstract][Full Text] [Related]
6. Receptor-interacting protein kinase 1 is a key mediator in TLR3 ligand and Smac mimetic-induced cell death and suppresses TLR3 ligand-promoted invasion in cholangiocarcinoma. Lomphithak T; Choksi S; Mutirangura A; Tohtong R; Tencomnao T; Usubuchi H; Unno M; Sasano H; Jitkaew S Cell Commun Signal; 2020 Oct; 18(1):161. PubMed ID: 33036630 [TBL] [Abstract][Full Text] [Related]
7. Smac mimetic promotes TNF-α to induce apoptosis of gallbladder carcinoma cells. Chen M; Huang M; Chen W; Jiang X; Su W; Wang X; Tang N; She F; Chen Y Cell Signal; 2020 Aug; 72():109654. PubMed ID: 32334028 [TBL] [Abstract][Full Text] [Related]
8. Overcoming cancer cell resistance to Smac mimetic induced apoptosis by modulating cIAP-2 expression. Petersen SL; Peyton M; Minna JD; Wang X Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11936-41. PubMed ID: 20547836 [TBL] [Abstract][Full Text] [Related]
9. Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1- and NF-κB-dependent manner. Wagner L; Marschall V; Karl S; Cristofanon S; Zobel K; Deshayes K; Vucic D; Debatin KM; Fulda S Oncogene; 2013 Feb; 32(8):988-97. PubMed ID: 22469979 [TBL] [Abstract][Full Text] [Related]
10. Smac mimetic increases chemotherapy response and improves survival in mice with pancreatic cancer. Dineen SP; Roland CL; Greer R; Carbon JG; Toombs JE; Gupta P; Bardeesy N; Sun H; Williams N; Minna JD; Brekken RA Cancer Res; 2010 Apr; 70(7):2852-61. PubMed ID: 20332237 [TBL] [Abstract][Full Text] [Related]
12. Smac modulates chemosensitivity in head and neck cancer cells through the mitochondrial apoptotic pathway. Sun Q; Zheng X; Zhang L; Yu J Clin Cancer Res; 2011 Apr; 17(8):2361-72. PubMed ID: 21242120 [TBL] [Abstract][Full Text] [Related]
13. Smac mimetics can provoke lytic cell death that is neither apoptotic nor necroptotic. Miles MA; Caruso S; Baxter AA; Poon IKH; Hawkins CJ Apoptosis; 2020 Aug; 25(7-8):500-518. PubMed ID: 32440848 [TBL] [Abstract][Full Text] [Related]
14. Birinapant (TL32711), a bivalent SMAC mimetic, targets TRAF2-associated cIAPs, abrogates TNF-induced NF-κB activation, and is active in patient-derived xenograft models. Benetatos CA; Mitsuuchi Y; Burns JM; Neiman EM; Condon SM; Yu G; Seipel ME; Kapoor GS; Laporte MG; Rippin SR; Deng Y; Hendi MS; Tirunahari PK; Lee YH; Haimowitz T; Alexander MD; Graham MA; Weng D; Shi Y; McKinlay MA; Chunduru SK Mol Cancer Ther; 2014 Apr; 13(4):867-79. PubMed ID: 24563541 [TBL] [Abstract][Full Text] [Related]
15. Differential role of RIP1 in Smac mimetic-mediated chemosensitization of neuroblastoma cells. Czaplinski S; Abhari BA; Torkov A; Seggewiß D; Hugle M; Fulda S Oncotarget; 2015 Dec; 6(39):41522-34. PubMed ID: 26575016 [TBL] [Abstract][Full Text] [Related]
16. Intermediate domain of receptor-interacting protein kinase 1 (RIPK1) determines switch between necroptosis and RIPK1 kinase-dependent apoptosis. Duprez L; Bertrand MJ; Vanden Berghe T; Dondelinger Y; Festjens N; Vandenabeele P J Biol Chem; 2012 Apr; 287(18):14863-72. PubMed ID: 22362767 [TBL] [Abstract][Full Text] [Related]
17. Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis. Petersen SL; Wang L; Yalcin-Chin A; Li L; Peyton M; Minna J; Harran P; Wang X Cancer Cell; 2007 Nov; 12(5):445-56. PubMed ID: 17996648 [TBL] [Abstract][Full Text] [Related]
18. SMAC mimetic (JP1201) sensitizes non-small cell lung cancers to multiple chemotherapy agents in an IAP-dependent but TNF-α-independent manner. Greer RM; Peyton M; Larsen JE; Girard L; Xie Y; Gazdar AF; Harran P; Wang L; Brekken RA; Wang X; Minna JD Cancer Res; 2011 Dec; 71(24):7640-8. PubMed ID: 22049529 [TBL] [Abstract][Full Text] [Related]
19. Smac mimetics and type II interferon synergistically induce necroptosis in various cancer cell lines. Cekay MJ; Roesler S; Frank T; Knuth AK; Eckhardt I; Fulda S Cancer Lett; 2017 Dec; 410():228-237. PubMed ID: 28923396 [TBL] [Abstract][Full Text] [Related]
20. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family. Basu A; Castle VP; Bouziane M; Bhalla K; Haldar S Cancer Res; 2006 Apr; 66(8):4309-18. PubMed ID: 16618756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]